Ironwood Pharmaceuticals, Inc. (IRWD) reported an adjusted loss of 2 cents per share for first-quarter 2024 in contrast to the Zacks Consensus Estimate of earnings of 18 cents per share. The company had recorded adjusted earnings of 25 cents per share in the year-ago quarter. Total revenues in the reported quarter were $74.9 million, which significantly missed the Zacks Consensus Estimate of$103 million. The top line decreased almost 28% year over year due to a $30.0 million gross-to-net change in estimate ...